Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: a structured summary of a study protocol for a randomised controlled trial

Peer Review reports

Original Submission
11 Mar 2021	Submitted	Original manuscript
12 Mar 2021	Author responded	Author comments - Nikhil Vergis
12 Mar 2021	Reviewed	Reviewer Report - Kirsty Loudon
Resubmission - Version 2
12 Mar 2021	Submitted	Manuscript version 2
12 Mar 2021	Reviewed	Reviewer Report - Kirsty Loudon
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
13 Mar 2021	Editorially accepted
12 Apr 2021	Article published	10.1186/s13063-021-05190-z

Back to article page